European Medicines Agency approves COVID-19 Vaccine Spikevax for children aged 12–17 years

Covid vaccine

COVID-19 Vaccine Spikevax (previously COVID-19 Vaccine Moderna) is now approved for use in children aged 12–17 years in the European Union

Please register to continue reading this content

Guidelines is completely free for all UK-based healthcare professionals